Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway

Clinical trial NCT07649629 · RECRUITING

Trial details

NCT number: NCT07649629
Sponsor: Regina Elena Cancer Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Advanced Non-small Cell Lung Cancer (NSCLC)

Start date: 2025-09-01
Primary completion: 2027-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.